The cause of multiple sclerosis is not exactly known.
Mechanisms
of disease progression
Recent studies have confirmed the mandatory
participation of the immune system - primary or secondary - in the pathogenesis
of multiple sclerosis. Disturbances in the immune system, as already mentioned,
are associated with the peculiarities of the set of genes that control the
immune response. The most widespread is the autoimmune theory of multiple
sclerosis to date, multiple sclerosis cannot yet be considered a completely
primary autoimmune disease. The occurrence of multiple sclerosis is associated
with a random individual combination of adverse endogenous and exogenous risk
factors. First of all, endogenous factors include a complex of HLA class II
gene loci and, possibly, genes encoding TNF-a, which determine the genetic
failure of immunoregulation. Among the external factors may be important: the
area of residence in childhood, nutritional habits, the frequency of viral and
bacterial infections, etc. In an organism that has a genetically determined
failure of the regulatory systems of immunity, the activation of the immune
system occurs - by trauma, a stressful situation. In this case, the antigen of
nonspecific provoking factors, for example, a viral infection - stimulated
macrophages and activated T-helpers are fixed on the endothelial cells of the
blood-brain barrier (BBB). Cytokines secreted by fixed cells express on the
surface of the BBB the major histocompatibility complex class I and II antigens
(for antigen presentation), as well as cell adhesion molecules.
Clinical
manifestations of multiple sclerosis
Clinical manifestations of multiple sclerosis are
associated with focal lesions of the heart, several different parts of the
brain and spinal cord, and other organs. Frequent symptoms of multiple
sclerosis are violations of the functions of the pelvic organs: imperative
urges, increased frequency, retention of urine and stool, in later stages -
incontinence. Incomplete emptying of the bladder is possible, which is often
the cause of a urological infection. Some patients may experience problems
associated with sexual function, which may coincide with dysfunction of the
pelvic organs or be an independent symptom. According to H.Livins et al.
(1976), changes in sexual life occur in 91% of men with multiple sclerosis and
72% of women. In 70% of patients, symptoms of visual impairment are detected: a
decrease in visual acuity of one or both eyes, a change in visual fields, the
appearance of scotomas, blurred images of objects, loss of vision brightness,
color distortion, contrast disturbance. In the process of aging, degeneration
of various organs occurs. Exceptionally often, such degeneration is associated
with the process of demyelination of the nerves that control this function.
Such neurological degeneration can be local - in one nerve, or it can be
multiple - in two or more nerves, up to a very significant number of nerve
formations. Thus, cardiac arrhythmia in the elderly is often associated with
the process of degeneration of the vagus nerve due to demyelination.
Resonance
therapy
Resonance was discovered by GaleleoGalelei in 1604
[2]. The resonance can be most clearly described as follows. A platoon of
soldiers approaches a wooden bridge and the officer gives the command to go out
of step because if a platoon of soldiers crosses the wooden bridge in step, the
bridge may collapse from resonance. The vibrations of the bridge will coincide
with the vibrations of the marching soldiers, a resonance will arise, from
which the bridge will collapse. In this review, the role of the bridge is
"played" by the disease, and the role of marching soldiers is
"performed" by the therapeutic effect. The commander of the soldiers
did not want the bridge to collapse due to possible resonance. The doctor, by
contrast, absolutely needs a resonance to destroy the disease. Resonance
methods for studying matter have found wide application in physics, chemistry,
biology, and medicine. For example, Nuclear Magnetic Resonance (NMR). At the
end of the 20th century, magnetic resonance imaging (MRI) was developed on the
basis of NMR. It is used to obtain images of the human brain, heart, and
digestive tract organs. For the development of MRI in 2003, the American
biophysicist Paul Lauterbur and his English colleague Peter Monsfield were
awarded the Nobel Prize in Physiology or Medicine. In 1975, the German
physician Frank Morell came to the quite logical conclusion that if a disease
of the organs of the human body is inevitably accompanied by disturbances in
their frequency rhythm, then the essence of treatment should be to suppress the
“unhealthy” fluctuations that have arisen and restore normal ones. Vegetative
resonance test - ART, originally proposed in 1991 by the German scientist G.
Schimmel, allows one-point examination [3]. Testing only one biologically
active point by him makes it possible to assess the state of not only all
organs and systems, but also their interconnections. A device for bioresonance
therapy based on a computer was created, which included both diagnostic and
therapeutic parts. In a modern device for bioresonance therapy there is a large
selector with diagnostic (they are also therapeutic) markers, information
copies of diseases, which are called "nosodes" when it comes to the
disease and "organ preparations" - information copies of healthy
organs when the doctor deals with normal, not pathological organs or their
parts. "Nosodes" are needed for the identification and treatment of
diseases, and "organ preparations" for testing perfectly healthy
organs or parts of them. Nosodes are electronic markers about a disease and
"organ preparations" - information markers about a healthy organ or
its part, recorded on a specific medium. Each test drug exerts a wave effect on
the patient. It is necessary to restore the spectral (frequency) harmony in the
patient. Original test preparations (unlike their informational copies) are
material objects, i.e. specific substances with their own atomic and molecular
structure.
Resonance
of destruction
Diagnosis
using destruction resonance
In the activity of a doctor applying bioresonance
therapy, a process takes place using modern technologies. First, a diagnosis is
made. To do this, the nosode of the alleged disease is displayed on the
computer screen connected to the device for bioresonance therapy and it is
tested in the patient. If the nosode is “not tested”, then there is no
resonance and the arrow on the computer screen does not fall down in the middle
of the screen. Therefore, the patient does not have the disease that is
displayed by the nosode. In the same case, if the nosode is being tested, there
is a resonance between the patient and the test drug - the arrow on the
computer screen falls and indicates that the patient has the disease, the name
of which is the nosode. This is a diagnostic resonance, but not a therapeutic
one. This is how resonance diagnostics is carried out in bioresonance therapy.